Grupul Pompidou

7/28/2019 Grupul Pompidou

1/19

Patrick Penninckx, Florence Mabileau

[email protected]

[email protected]/Pompidou

Presidency of the Council of Ministers Rome, 19 June 2012

The Pompidou Group and

the cooperation in theMediterranean Region
mailto:[email protected]:[email protected]://www.coe.int/http://www.coe.int/Pompidouhttp://www.coe.int/Pompidouhttp://www.coe.int/mailto:[email protected]:[email protected]


2/19

The European Framework

1949 : oldest political

organisation in Europe,

Strasbourg

Aim : create a common

democratic and legal area in

Europe (47 countries) with

respect of fundamental values :

human rights, democracy and

the rule of law

DG I

Human Rights and

Rule of Law

1971: Pompidou Group

1980: partial agreement

Council of Europe European Union

European Commission

DG - Justice, Freedom and

security, Brussels

EU Drugs Strategy 2005-2012

Action Plan 2009-2012

EMCDDA

1993 in Lisbon

Role = provide the EUand its Member States

with an overview of

European drug problems

1


3/19

(Co-operation Group to Combat Drug Abuse and Illicit Trafficking in Drugs)

intergovernmental body set up in 1971 at the suggestion of the

French President Georges Pompidou.

Informal co-operation forum of 7 European countries (France, Belgium,

Germany, Italy, Luxembourg, Netherlands, United Kingdom) to share experience

with combating drug abuse and drug trafficking.

Integrated into the Council of Europe in 1980 as enlarged agreement

Co-operation includes countries towards Central and Eastern Europe

(Ukraine) and the Mediterranean Region with MedNET.

2012 : 36 member states. Morocco: most recent one.

2

The Pompidou Group


4/19

Mission: contributes to the development of multidisciplinary, innovative,

effective and evidence-based drug policies in 35 member states.

links policy, practice and science.

multidisciplinary forum at the wider European level where it is possible for

policy-makers, professionals and researchers to discuss and exchange

information and ideas on drug misuse and trafficking problems.

bridging role between EU countries and non-EU countries (Federation of

Russia, Ukraine) as well as countries from the Mediterranean Region

Follows Council of Europe values on respect of human rights.

3

The Role ofthe Pompidou Group


5/19

Secretariat in Strasbourg, Council of Europe

Ministerial Conference (held every 4 years) -> adopts work programme

France chairs the Group for the mandate 2011-2014

Permanent Correspondents = representatives of the 36 member states; senior

officials in ministries in charge of drug issues implement the programme.

The Pompidou Group covers demand reduction and supply reduction activities

including research which plays a role for formulating drug policy.

Activities are funded on the ordinary budget (yearly contributions by the

Member States) and voluntary contributions made for specific activities.

Activities are decided each year to take into account emerging concerns.

4

The Pompidou Groups organisation


6/19

Road traffic and substitution treatment: to get an overview of approaches

in Europe and define good practice, both medical and legal.

Prevention of chemical precursors diversion and illegal production through rapid

and direct contact among law enforcement officers and representatives ofregulatory boards

Airports group : development and harmonisation of tools and systems to improve

drug detection in European airports

Prevention of drug use in the work place

5

Activities in 2012


7/19

Created in 2004 to recognise the importance of active

youth participation in drug prevention projects.

Only prize granted for young people

Awarded every 2 years -> 2004-2012 by a jury of 6

young people

3 drug prevention projects led by youth for youth arerewarded for their work.

Monetary benefit: 5000, trophy and diploma

In 2006 : 31 applications from 18 countries

In 2012 : 83 applications from 24 countries

Winners in 2010 : Spain, UK, Belgium

The European

Drug Prevention Prize

6


8/19

Research on the comparison of coherent drug policies to address the following :

what are the best structures to reach coherent drug policies?

what models could be used to measure a coherent policys effectiveness?

reflections on the concept for a policy on psychoactive substances and beyond

Policy paper to provide guidance to policy makers for developing coherentpolicies for licit and illicit drugs

Executive training on drug policy

ESPAD European school survey on alcohol and other Drugs :

Support to participation of non EU countries in the ESPAD

Project to optimize communication between researchers and policy-makers on ESPAD

7

Activities in 2012


9/19

Set up in 2007 as a network between stakeholders at the

frontline level at city, regional and national level

Aim: Connects professionals and Permanent

Correspondents to provide insights into policy

implementation on topics of immediate concern to

governments.

Addresses specific topics:

October, 2011- How Services Deal with Poly-Drug Use

March, 2012 : Drug policy cooperation in South-East Europe

EXASS NET

Member countries: Germany, Croatia, Russian Federation, Finland, Hungary, Moldova, Norway,Netherland, Poland, Portugal, Romania, Slovenia, Ukraine, United-Kingdom

Member cities: Amsterdam, Budapest, Cracow, Frankfurt, Koper, Oslo, Preston, Turku, Viseu, Zagreb,Zaporozhye

8


10/19

9

The MedNET network of cooperation

on drugs and drug addiction

Aim: promotes cooperation exchange and

two-way transfer knowledge on drugs and

drug addiction between countries of both

rims of the Mediterranean (North-South

and South-North exchanges) as well as

within countries of the Mediterranean

(South-South exchanges).

13 countries = Algeria, Cyprus, Egypt,

France, Greece, Italy, Jordan, Lebanon,

Malta, Morocco, Portugal, Spain, Tunisia

Activities meet countries needs for capacity

building and information exchange.


11/19

Setting up and development

1999 : First conference about cooperation in the Mediterranean Region in Malta

2003 : Launch of the MedSPAD (Mediterranean adaptation of European School

Survey project) in Rabat

2006 : MedNET network set up after feasibility study by France and Netherlands

2008 : First MedSPAD in Lebanon and Morocco

2009 : First high level conference acknowledges the role of PG in fostering

cooperation between the countries of the Mediterranean

2011 : Morocco: first non Council of Europe country to join Pompidou Group

2012 : 13 Member countries = Algeria, Cyprus, Egypt, France, Greece, Italy,Jordan, Lebanon, Malta, Morocco, Portugal, Spain, Tunisia

10


12/19

11

In each country, the Minister in charge of drug issues nominates a national representative

who participates in the biannual MedNET meetings.

The country representative presents a proposal for work based on their needs. These

proposals are adopted by all the MedNET representatives. These proposals made up the

annual work programme.

A Secretariat based within the Pompidou Group at the Council of Europe in Strasbourg

administers and coordinates the work programme (flexibility according to priorities).

The budget is made up of voluntary contributions.

A yearly activity report assesses the work programme.

Network open to outside experts (Norway, Ireland, Switzerland, UK) share their expertise.

MedNET invites international organisations according to the topic dealt with.

How does the network operate ?


13/19

12

MedNET Activities (2010-2012)

Activities per country

Algeria,

Seminars to train medical staff in the treatment of drug users

Seminars on law enforcement including precursors

Morocco,

Training of medical staff through setting up of addictology courses atuniversity (funded by Italy)

Introduction to opiate substitution treatment through training in France and

Switzerland

Prevention material (funded by Italy)

Tunisia,Official visit in October 2011 after the revolution followed with the first

consultative seminar in May 2012 to develop a drug strategy and an

observatory on drugs and drug addiction


14/19

13

MedNET Activities (2010-2012)

Jordan,

Vocational training for experts in Malta

Collection of data on treatment from treatment centres

Lebanon,

Assessment of the needs for treatment of drug users with recommendations tochange the law included a visit in France

Training of prevention agents

Egypt,

Assessment of the needs for treatment of drug users with recommendations to

change the law included a visit in UK and in Italy (funded by Italy)Project on the gender oriented care of substance dependent women (funded by

Italy)


15/19

14

MedNET Activities (2010-2012)Regional activities

Regional training seminars, the objective is to introduce the participants to the

concept of national observatories on drugs and drug addiction :

Seminar on treatment, Cairo,

Seminar on data collection, Amann,

Seminar on synthetic drugs, precursors, supply indicators, Beirut,

Seminar to lay the foundations for setting up national monitoring centres, Rabat,

Workshop to set up national monitoring centres, Brussels,

Seminar on the use of research in policy in the Mediterranean Region, Rabat,

Seminar on trafficking in airports to be held in Madrid.


16/19

15

Added value of the MedNET

Adaptation of methodology recognised in Europe to the Mediterranean context

A wide range of activities to get a comprehensive approach to the drug problem

A bridging role between Europe and the Southern part of the Mediterranean

Exchange of knowledge and experience within the countries of the South

Activities based on real needs expressed by the countries

Flexibility in the implementation of programmes

Regular evaluation by all stakeholders

Cost effectiveness


17/19

16

Outlook for the future

Continuation of the work programme of the MedNET network.

Consolidation of the membership in continuing to replying to the countries needs

Extension to other countries if interested.

Keeping the interest of the donors countries.

Access to MedNET could be a first step towards accession to the Pompidou

Group.

Promoting MedNET as a forum where countrys needs are listened to, where

experience is shared, where methodology is adapted to each country with a view

of improving the implementation of a coherent drug policy based on health in all

participating countries, taking into account the cultural factors.


18/19

For further information, please visit our website

http://www.coe.int/t/dg3/pompidou/default_en.asp

Or contact our Secretariat directly

Pompidou Group

Council of Europe

F - 67075 Strasbourg - CEDEX

[email protected]

17
http://www.coe.int/t/dg3/pompidou/default_en.aspmailto:[email protected]:[email protected]://www.coe.int/t/dg3/pompidou/default_en.asp


19/19

Thank you for your attention!

[email protected]

[email protected]/Pompidou

18
mailto:[email protected]:[email protected]://www.coe.int/Pompidouhttp://www.coe.int/Pompidoumailto:[email protected]:[email protected]

Documents

Grupul Pompidou